MANNINI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.063
EU - Europa 2.329
AS - Asia 1.685
SA - Sud America 227
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 46
OC - Oceania 26
Totale 7.460
Nazione #
US - Stati Uniti d'America 2.996
PL - Polonia 763
RU - Federazione Russa 662
SG - Singapore 484
CN - Cina 471
IT - Italia 385
HK - Hong Kong 183
KR - Corea 171
BR - Brasile 169
VN - Vietnam 149
IE - Irlanda 109
SE - Svezia 94
IN - India 84
DE - Germania 76
FI - Finlandia 68
FR - Francia 51
CA - Canada 36
CH - Svizzera 35
GB - Regno Unito 34
ID - Indonesia 29
AU - Australia 26
BD - Bangladesh 18
AR - Argentina 15
JO - Giordania 14
NG - Nigeria 14
TR - Turchia 13
ES - Italia 12
IQ - Iraq 12
JP - Giappone 12
MX - Messico 12
NL - Olanda 12
CO - Colombia 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 8
ZA - Sudafrica 7
JM - Giamaica 6
PY - Paraguay 6
UA - Ucraina 6
VE - Venezuela 6
BJ - Benin 5
MA - Marocco 5
MY - Malesia 5
AL - Albania 4
CL - Cile 4
IL - Israele 4
PE - Perù 4
PH - Filippine 4
UY - Uruguay 4
AM - Armenia 3
AT - Austria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
LT - Lituania 3
PK - Pakistan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
MR - Mauritania 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.377
Città #
Santa Clara 767
Warsaw 763
Ashburn 407
Singapore 365
Hefei 179
Fairfield 177
Hong Kong 163
Seoul 161
San Jose 137
Chandler 127
Dublin 109
Council Bluffs 96
Seattle 85
Woodbridge 79
Milan 72
Houston 71
Wilmington 69
Cambridge 66
Florence 56
Ho Chi Minh City 53
Los Angeles 51
The Dalles 49
Beijing 43
Lawrence 41
Moscow 40
Lauterbourg 38
Altamura 36
Rome 29
Mumbai 28
Buffalo 26
Princeton 26
Hanoi 25
Helsinki 24
Melbourne 24
Pune 24
Munich 23
Ann Arbor 22
Bremen 22
Jakarta 22
Atlanta 21
Boardman 21
Boston 21
Kent 21
Phoenix 21
Dallas 18
Shanghai 16
Lappeenranta 15
Naples 15
Turku 15
Abuja 14
Basel 13
San Diego 13
Dong Ket 12
Chennai 11
New York 11
Turin 11
Medford 10
Milwaukee 10
Bengaluru 9
Bern 9
Cagliari 9
Da Nang 9
Haiphong 9
Seongnam 9
São Paulo 9
Barcelona 8
Brasília 8
Frankfurt am Main 8
London 8
Norwalk 8
Tokyo 8
Bologna 7
Clifton 7
Dübendorf 7
Falls Church 7
Jacksonville 7
Orem 7
Toronto 7
Abu Dhabi 6
Belo Horizonte 6
Chicago 6
Denver 6
Groningen 6
Philadelphia 6
Rio de Janeiro 6
Serra 6
Tianjin 6
Virginia Beach 6
Amman 5
Baghdad 5
Cotonou 5
Hillsboro 5
Izmir 5
Manchester 5
Montreal 5
Paris 5
Brooklyn 4
Catania 4
Guangzhou 4
Kingston 4
Totale 5.160
Nome #
A causative link between the structure of aberrant protein oligomers and their toxicity 491
Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils 358
Effect of molecular chaperones on aberrant protein oligomers in vitro: super- versus sub-stoichiometric chaperone concentrations 315
Early-forming aberrant aggregates in protein deposition diseases: structural characteristics, interaction with molecular chaperones, ability to trigger inflammation 311
Toxic HypF-N oligomers selectively bind the plasma membrane to impair cell adhesion capability 284
Multistep Inhibition of α‑Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine 255
The induction of α-helical structure in partially unfolded HypF-N does not affect its aggregation propensity 220
Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity 214
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells 200
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 200
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers 197
Glycosaminoglycans (GAGs) Suppress the Toxicity of HypF-N Prefibrillar Aggregates 188
Squalamine and its derivatives modulate the aggregation of amyloid-β and α-synuclein and suppress the toxicity of their oligomers 183
Aβ oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors. 173
Bis(indolyl)phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme 173
SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads 172
Chaperones suppress protein oligomer toxicity: Insight into the molecular mechanism of action 167
Differential interactome and innate immune response activation of two structurally distinct misfolded protein oligomers 167
Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state. 162
Small-molecule sequestration of amyloid-beta. as a drug discovery strategy for Alzheimer's disease 160
Distinct responses of human peripheral blood cells to different misfolded protein oligomers 159
Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism 157
Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity 151
Chaperones suppress the toxicity of aberrant protein aggregates. Molecular insight into the mechanism of action 141
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity 137
Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans 136
Stabilization and Characterization of Cytotoxic Aβ40 Oligomers Isolated from an Aggregation Reaction in the Presence of Zinc Ions 135
Therapeutic strategies to reduce the toxicity of misfolded protein oligomers 129
Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response 124
A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions 123
Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers 122
Rationally designed antibodies as research tools to study the structure–toxicity relationship of amyloid-β oligomers 121
Proteome-wide observation of the phenomenon of life on the edge of solubility 119
A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease 114
Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles 114
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers 113
Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates 109
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease 107
Single molecule secondary structure determination of proteins through infrared absorption nanospectroscopy 107
Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates 106
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers 96
Targeting Protein Aggregation in ALS 94
Small Molecule Inhibitors for Precise Inhibition of Alpha-Synuclein Oligomer Generation in Parkinson’s Disease (S32.002) 92
Berberine mitigates neurotoxicity of misfolded protein oligomers by interacting with the cell membrane and subsequent internalization, without altering their structure 64
Totale 7.460
Categoria #
all - tutte 20.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 0 16 5 3 7 8 14 10 9 18 46
2022/2023562 37 109 36 52 44 104 66 32 50 3 16 13
2023/2024274 9 28 27 9 9 42 10 50 4 61 14 11
2024/20252.010 49 215 87 266 662 259 41 64 125 41 83 118
2025/20262.670 255 361 338 215 253 109 311 135 198 157 85 253
2026/2027241 87 54 100 0 0 0 0 0 0 0 0 0
Totale 7.460